Request for a License to Export Deuterium, 12207-12208 [2015-05318]
Download as PDF
Federal Register / Vol. 80, No. 44 / Friday, March 6, 2015 / Notices
Dated: March 2, 2015.
Suzanne Plimpton,
Acting, Committee Management Officer.
[FR Doc. 2015–05255 Filed 3–5–15; 8:45 am]
BILLING CODE 7555–01–P
NATIONAL SCIENCE FOUNDATION
Federal-Commercial Spectrum Sharing
Workshop: Models, Application, and
Impacts of Incentives for Sharing
The National Coordination
Office (NCO) for Networking and
Information Technology Research and
Development (NITRD).
ACTION: Notice.
AGENCY:
The Wireless Spectrum R&D
Senior Steering Group (WSRD SSG) has
been conducting a series of workshops
on understanding the fundamental
issues involved in Federal and
Commercial Spectrum Sharing. The
seventh workshop in this series will
focus on incentives. This workshop
titled, ‘‘Federal-Commercial Spectrum
Sharing: Models, Applications, and
Impacts of Incentives for Sharing’’, will
be held on March 19, 2015, from 8:00
a.m. to 5:30 p.m., at the Stevens
Institute of Technology, Hoboken, NJ.
The workshop will be Webcast and the
link will be made available at: https://
www.nitrd.gov/nitrdgroups/
index.php?title=Wireless_Spectrum_
Research_and_Development_
(WSRD)#title. Information gathered from
this workshop will be used by the
WSRD SSG to develop
recommendations for the White House
Office of Science and Technology Policy
(OSTP).
DATES: March 19, 2015.
Background: The WSRD SSG
workshop series stems from the June 14,
2013 Presidential Memorandum,
Expanding America’s Leadership in
Wireless Innovation, to make more
wireless spectrum available for
commercial use by encouraging shared
access by commercial and federal users.
One of the directives was to explore and
recommend market-based or other
approaches that would incentivize
Federal and commercial users to
cooperate in sharing spectrum. Different
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:59 Mar 05, 2015
Jkt 235001
groups have proposed a variety of
budgetary and administrative incentives
for Federal agencies. Proposals have
included introduction of a spectrum
currency and setting aside some portion
of spectrum auction revenues to
establish a spectrum efficiency or
relocation fund. Internationally, the
United Kingdom has explored charging
spectrum usage fees to government
agencies.
Rich and multidisciplinary research
questions arise when considering
incentives for bi-directional spectrum
sharing. Sharing between government
and commercial entities will require
innovations in technology as well as in
business, administrative, and market
institutions and practices. Federal,
public safety, and commercial users
confront different constraints and
strategic options, and can be expected to
respond differently to opportunities and
incentives. This workshop will discuss
what research is needed to get a better
understanding of these factors,
including lessons learned, in order to
identify incentives that will work.
Submitted by the National Science
Foundation for the National
Coordination Office (NCO) for
Networking and Information
Technology Research and Development
(NITRD) on February 25, 2015.
FOR FURTHER INFORMATION CONTACT:
Wendy Wigen at 703–292–4873 or
wigen@nitrd.gov. Individuals who use a
telecommunications device for the deaf
(TDD) may call the Federal Information
Relay Service (FIRS) at 1–800–877–8339
between 8 a.m. and 8 p.m., Eastern time,
Monday through Friday.
Suzanne H. Plimpton,
Reports Clearance Officer, National Science
Foundation.
[FR Doc. 2015–04236 Filed 3–5–15; 8:45 am]
BILLING CODE 7555–01–P
NUCLEAR REGULATORY
COMMISSION
Request for a License to Export
Deuterium
Pursuant to Title 10 of the Code of
Federal Regulations (10 CFR) 110.70 (b)
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
12207
‘‘Public Notice of Receipt of an
Application,’’ please take notice that the
U.S. Nuclear Regulatory Commission
(NRC) has received the following
request for an export license. Copies of
the request are available electronically
through the Agencywide Documents
Access and Management System and
can be accessed through the Public
Electronic Reading Room link https://
www.nrc.gov/reading-rm.html at the
NRC Homepage.
A request for a hearing or petition for
leave to intervene may be filed within
thirty days after publication of this
notice in the Federal Register (FR). Any
request for hearing or petition for leave
to intervene shall be served by the
requestor or petitioner upon the
applicant, the Office of the General
Counsel, U.S. Nuclear Regulatory
Commission, Washington, DC 20555;
the Office of Secretary, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555; and the Executive Secretary,
U.S. Department of State, Washington,
DC 20520.
A request for a hearing or petition for
leave to intervene may be filed with the
NRC electronically in accordance with
NRC’s E-Filing rule promulgated in
August 2007, 72 FR 49139; Aug. 28,
2007. Information about filing
electronically is available on the NRC’s
public Web site at https://www.nrc.gov/
site-help/e-submittals.html. To ensure
timely electronic filing, at least five days
prior to the filing deadline, the
petitioner/requestor should contact the
Office of the Secretary by email at
HEARINGDOCKET@NRC.GOV, or by
calling (301) 415–1677, to request a
digital ID certificate and allow for the
creation of an electronic docket.
In addition to a request for hearing or
petition for leave to intervene, written
comments, in accordance with 10 CFR
110.81, should be submitted within
thirty days after publication of this
notice in the FR to Office of the
Secretary, U.S. Nuclear Regulatory
Commission, Washington, DC 20555,
Attention: Rulemaking and
Adjudications.
The information concerning this
export license application follows.
E:\FR\FM\06MRN1.SGM
06MRN1
12208
Federal Register / Vol. 80, No. 44 / Friday, March 6, 2015 / Notices
NRC EXPORT LICENSE APPLICATION
Description of Material
Name of applicant date of application
date received
application no.
docket no.
Material type
Total
quantity
End use
Recipient
country
Concert Pharmaceuticals, Inc., February 12,
2015, February 20, 2015, XMAT434, 11006190.
Heavy water
(D2O).
∼20,000.0 kgs
Non-nuclear end-use in active pharmaceutical ingredient manufacturing.
Switzerland.
Dated this 26th day of February, 2015 at
Rockville, Maryland.
For the U.S. Nuclear Regulatory
Commission.
David L. Skeen,
Deputy Director, Office of International
Programs.
Isotopes (Public Meeting) (Contact:
Nima Ashkeboussi, 301–415–5775)
This meeting will be webcast live at
the Web address—https://www.nrc.gov/.
9:30 a.m.—Meeting with the
Organization of Agreement States and
the Conference of Radiation Control
Program Directors (Public Meeting)
Contact: Nima Ashkeboussi, 301–415–
5775)
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2015–0001]
Sunshine Act Meeting Notice
DATES:
March 9, 16, 23, 30, April 6, 13,
2015.
Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public and Closed.
PLACE:
Week of March 9, 2015
There are no meetings scheduled for
the week of March 9, 2015.
Week of March 16, 2015—Tentative
There are no meetings scheduled for
the week of March 16, 2015.
Week of March 23, 2015—Tentative
Thursday, March 26, 2015
9:30 a.m.—Briefing on Security Issues
(Closed—Ex. 1)
1:30 p.m.—Briefing on Security Issues
(Closed—Ex. 1)
Friday, March 27, 2015
9:30 a.m.—Briefing on Threat
Environment Assessment (Closed—
Ex. 1)
Week of March 30, 2015—Tentative
mstockstill on DSK4VPTVN1PROD with NOTICES
There are no meetings scheduled for
the week of March 30, 2015.
Week of April 6, 2015—Tentative
There are no meetings scheduled for
the week of April 6, 2015.
Week of April 13, 2015—Tentative
Tuesday, April 14, 2015
9:30 a.m.—Meeting with the Advisory
Committee on the Medical Uses of
VerDate Sep<11>2014
19:46 Mar 05, 2015
Jkt 235001
This meeting will be webcast live at
the Web address—https://www.nrc.gov/.
*
*
*
*
*
The schedule for Commission
meetings is subject to change on short
notice. For more information or to verify
the status of meetings, contact Glenn
Ellmers at 301–415–0442 or via email at
Glenn.Ellmers@nrc.gov.
*
*
*
*
*
The NRC Commission Meeting
Schedule can be found on the Internet
at: https://www.nrc.gov/public-involve/
public-meetings/schedule.html.
*
*
*
*
*
The NRC provides reasonable
accommodation to individuals with
disabilities where appropriate. If you
need a reasonable accommodation to
participate in these public meetings, or
need this meeting notice or the
transcript or other information from the
public meetings in another format (e.g.
braille, large print), please notify
Kimberly Meyer, NRC Disability
Program Manager, at 301–287–0727, by
videophone at 240–428–3217, or by
email at Kimberly.Meyer-Chambers@
nrc.gov. Determinations on requests for
reasonable accommodation will be
made on a case-by-case basis.
*
*
*
*
*
Members of the public may request to
receive this information electronically.
If you would like to be added to the
distribution, please contact the Nuclear
Regulatory Commission, Office of the
Secretary, Washington, DC 20555 (301–
415–1969), or email
Brenda.Akstulewicz@nrc.gov or
Patricia.Jimenez@nrc.gov.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
[FR Doc. 2015–05382 Filed 3–4–15; 4:15 pm]
BILLING CODE 7590–01–P
Thursday, April 16, 2015
[FR Doc. 2015–05318 Filed 3–5–15; 8:45 am]
Dated: March 4, 2015.
Glenn Ellmers,
Policy Coordinator, Office of the Secretary.
PENSION BENEFIT GUARANTY
CORPORATION
Proposed Submission of Information
Collection for OMB Review; Comment
Request; Annual Financial and
Actuarial Information Reporting
Pension Benefit Guaranty
Corporation.
AGENCY:
ACTION:
Notice; correction.
The Pension Benefit Guaranty
Corporation (PBGC) published a
document in the Federal Register on
March 2, 2015, concerning a proposed
submission of an information collection
on Annual Financial and Actuarial
Information Reporting for OMB review.
The document contained an inadvertent
error in the subject heading.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Grace Kraemer, Attorney, or Catherine
B. Klion, Assistant General Counsel,
Office of the General Counsel, Pension
Benefit Guaranty Corporation, 1200 K
Street NW., Washington, DC 20005–
4026; 202–326–4024. (TTY and TDD
users may call the Federal relay service
toll-free at 1–800–877–8339 and ask to
be connected to 202–326–4024.)
Correction
In the Federal Register of March 2,
2015, in 80 FR 11240, correct the subject
heading to read:
Proposed Submission of Information
Collection for OMB Review; Comment
Request; Annual Financial and Actuarial
Information Reporting
Issued in Washington, DC, this 2nd day of
March, 2015.
Catherine B. Klion,
Assistant General Counsel, Pension Benefit
Guaranty Corporation.
[FR Doc. 2015–05126 Filed 3–5–15; 8:45 am]
BILLING CODE 7709–02–P
E:\FR\FM\06MRN1.SGM
06MRN1
Agencies
[Federal Register Volume 80, Number 44 (Friday, March 6, 2015)]
[Notices]
[Pages 12207-12208]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-05318]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Request for a License to Export Deuterium
Pursuant to Title 10 of the Code of Federal Regulations (10 CFR)
110.70 (b) ``Public Notice of Receipt of an Application,'' please take
notice that the U.S. Nuclear Regulatory Commission (NRC) has received
the following request for an export license. Copies of the request are
available electronically through the Agencywide Documents Access and
Management System and can be accessed through the Public Electronic
Reading Room link https://www.nrc.gov/reading-rm.html at the NRC
Homepage.
A request for a hearing or petition for leave to intervene may be
filed within thirty days after publication of this notice in the
Federal Register (FR). Any request for hearing or petition for leave to
intervene shall be served by the requestor or petitioner upon the
applicant, the Office of the General Counsel, U.S. Nuclear Regulatory
Commission, Washington, DC 20555; the Office of Secretary, U.S. Nuclear
Regulatory Commission, Washington, DC 20555; and the Executive
Secretary, U.S. Department of State, Washington, DC 20520.
A request for a hearing or petition for leave to intervene may be
filed with the NRC electronically in accordance with NRC's E-Filing
rule promulgated in August 2007, 72 FR 49139; Aug. 28, 2007.
Information about filing electronically is available on the NRC's
public Web site at https://www.nrc.gov/site-help/e-submittals.html. To
ensure timely electronic filing, at least five days prior to the filing
deadline, the petitioner/requestor should contact the Office of the
Secretary by email at HEARINGDOCKET@NRC.GOV, or by calling (301) 415-
1677, to request a digital ID certificate and allow for the creation of
an electronic docket.
In addition to a request for hearing or petition for leave to
intervene, written comments, in accordance with 10 CFR 110.81, should
be submitted within thirty days after publication of this notice in the
FR to Office of the Secretary, U.S. Nuclear Regulatory Commission,
Washington, DC 20555, Attention: Rulemaking and Adjudications.
The information concerning this export license application follows.
[[Page 12208]]
NRC EXPORT LICENSE APPLICATION
Description of Material
----------------------------------------------------------------------------------------------------------------
Name of applicant date of
application date received Material type Total quantity End use Recipient country
application no. docket no.
----------------------------------------------------------------------------------------------------------------
Concert Pharmaceuticals, Inc., Heavy water (D2O). ~20,000.0 kgs..... Non-nuclear end- Switzerland.
February 12, 2015, February 20, use in active
2015, XMAT434, 11006190. pharmaceutical
ingredient
manufacturing.
----------------------------------------------------------------------------------------------------------------
Dated this 26th day of February, 2015 at Rockville, Maryland.
For the U.S. Nuclear Regulatory Commission.
David L. Skeen,
Deputy Director, Office of International Programs.
[FR Doc. 2015-05318 Filed 3-5-15; 8:45 am]
BILLING CODE 7590-01-P